Fig. 1From: The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectivesmicroRNAs regulate multiple AD-related cellular and molecular pathways. In healthy brain, miRNAs can maintain homeostasis through negative regulation of targets in neuronal and immune pathways. In Alzheimer’s brain, miRNAs are dysregulated impacting cellular and molecular cascades involved in AD endophenotypes.Back to article page